B
Bobby L. Boyanton
Professor; Pathologist-in-Chief
University of Arkansas for Medical Sciences
faculty
16 h-index
70 pubs
1,153 cited
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Bobby L. Boyanton Jr.'s research focuses on infectious diseases and public health, with a particular emphasis on pediatric populations and the impact of the SARS-CoV-2 pandemic. His work has investigated the seroprevalence of SARS-CoV-2 in Arkansas children and the effects of non-pharmacologic interventions on respiratory infections. Boyanton has also studied the mitigation strategies for SARS-CoV-2 that have concomitantly reduced infections from other pathogens, including Group A Streptococcus and Methicillin-Resistant Staphylococcus aureus.
His research interests extend to other infectious agents and conditions, such as Histoplasma capsulatum infective endocarditis and locally acquired malaria in Arkansas. Boyanton's publications also touch upon the implementation of pharmacogenomics testing and reviews of pharyngitis pathogens. He has collaborated with Joshua L. Kennedy, Ashton Ingold, Dana Frederick, and Catherine Kirkpatrick at the University of Arkansas for Medical Sciences on multiple publications.
Metrics
- h-index: 16
- Publications: 70
- Citations: 1,153
Selected Publications
- Photo Quiz: Persistent dysuria and hematuria in a 9-year-old male (2026) DOI
- Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions (2026) DOI
- Photo Quiz: A camper with fever, headache, and fatigue (2026) DOI
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma (2025) DOI
- Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology study (2025) DOI
- Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps (2024) DOI
- Review: Known, Emerging, and Remerging Pharyngitis Pathogens (2024) DOI
- Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers (2024) DOI
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas (2024) DOI
- <i>NR3C2</i> microdeletions—an underrecognized cause of pseudohypoaldosteronism type 1A: a case report and literature review (2024) DOI
- Improving Pediatric Clostridioides difficile Testing Practices: Implementation of a 2-Tier Diagnostic Pathway (2023) DOI
- SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to <i>Mycoplasma pneumoniae</i> and Co-Infecting Respiratory Viruses in Arkansas (2023) DOI
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced (2023) DOI
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas (2023) DOI
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis (2022) DOI
Grants & Funding
Collaboration Network
Top Collaborators
Joshua L. Kennedy
University of Arkansas for Medical Sciences
11 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
Showing 5 of 11 shared publications
Rachel A. Frenner
Arkansas Children's Hospital (US)
7 shared publications
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
- SARS-CoV-2 Prevention Measures Concomitantly Attenuate <i>Methicillin-Resistant Staphylococcus aureus</i> Infection Rates
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
Showing 5 of 7 shared publications
Ashton Ingold
University of Arkansas for Medical Sciences
7 shared publications
In database
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
- SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to <i>Mycoplasma pneumoniae</i> and Co-Infecting Respiratory Viruses in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
Showing 5 of 7 shared publications
Susanna Hartzell
5 shared publications
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
- Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions
Dana Frederick
University of Arkansas for Medical Sciences
5 shared publications
In database
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
- Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions
Jessica Snowden
University of Arkansas for Medical Sciences
4 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- 1710. <i>Clostridioides difficile</i> Bundle Implementation Reduces Unnecessary Testing in Pediatric Patients
Katherine Caid
University of Arkansas for Medical Sciences (US)
4 shared publications
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
Karl W. Boehme
Winthrop Rockefeller Foundation (US)
3 shared publications
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers
Similar Researchers
Based on overlapping research topics
Amairani Paredes
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
COVID-19 epidemiological studies
Maxwell D. Taylor
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
COVID-19 epidemiological studies
Claire Putt
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
COVID-19 epidemiological studies
David Church
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Immune Response and Inflammation
Dana Frederick
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
COVID-19 epidemiological studies
Tran Ngoc Phuong
University of Arkansas at Little Rock
Microbial infections and disease research
COVID-19 epidemiological studies
Child and Adolescent Health